Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v4-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-04-06 | 2025-03-06 |
| Drug Identification Number | 02537893 | 02537893 |
| Brand name | ACETAZOLAMIDE FOR INJECTION USP | ACETAZOLAMIDE FOR INJECTION USP |
| Common or Proper name | ACETAZOLAMIDE FOR INJECTION USP 500 MG/VIAL | ACETAZOLAMIDE FOR INJECTION USP 500 MG/VIAL |
| Company Name | MARCAN PHARMACEUTICALS INC | MARCAN PHARMACEUTICALS INC |
| Ingredients | ACETAZOLAMIDE | ACETAZOLAMIDE |
| Strength(s) | 500MG | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 1X1 VIAL | 1X1 VIAL |
| ATC code | S01EC | S01EC |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2025-03-01 | 2025-03-01 |
| Actual start date | 2025-03-03 | 2025-03-03 |
| Estimated end date | 2025-05-31 | 2025-05-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Some stocks are available at McKesson and CPDN | |
| Health Canada comments |